- Citations, last 5 years
- 9 950
- Works, last 5 years
- 1 402
- h-index
- 502
- Scientists listed
- 0
- Grants since 2016
- 608
Grants received
2025–2026 · grant · Standard Grant
Conference: Quantum Industry Roundtable
Annie Wyhof · SRI International · funded by National Science Foundation
2025–2028 · grant · Continuing Grant
Collaborative Research: DASI Track 2--A Distributed Meteor Radar and Optical Network in South America
Asti Bhatt · SRI International · funded by National Science Foundation
2025–2028 · grant · Standard Grant
Badging Professional Skills in CTE Programs
Louise Yarnall · SRI International · funded by National Science Foundation
2025–2028 · grant · Standard Grant
Collaborative Research: TogetherCS: A Systematic Investigation of Collaborative Programming Models for Upper Elementary School
Satabdi Basu · SRI International · funded by National Science Foundation
2025–2028 · grant · Standard Grant
CEDAR: Studies of the O2(a-X) Infrared Atmospheric Band Nightglow Emission
Konstantinos Kalogerakis · SRI International · funded by National Science Foundation
2025–2026 · contract · N01
Pharmacokinetics of Long-Acting Preparations of Antitubercular Drugs in Rodents
Maria Arolfo · SRI International · funded by National Institutes of Health
2025–2027 · research · R21
Thermoregulatory Physiology of Menopausal Hot Flashes
Fiona C Baker · SRI International · funded by National Institutes of Health
2025–2028 · contract · N01
GLP Toxicology Study for Adjuvanted HIV-1 Immunogen Vaccine Candidates
Deborah Bunin · SRI International · funded by National Institutes of Health
2025–2026 · contract · N01
NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLE
Deborah Bunin · SRI International · funded by National Institutes of Health
2025–2027 · contract · N01
NICHD: R&D: ESSENTIAL STUDIES AND MANUFACTURE FOR CURRENT PRODUCTS IN ONGOING CLINICAL DEVELOPMENT: NON-SEVERABLE
Deborah Bunin · SRI International · funded by National Institutes of Health
2025–2026 · contract · N01
NICHD: R&D: BIOLOGICAL TESTING FACILITY - DRUG PRODUCT MANUFACTURE OF ONGOING CLINICAL DEVELOPMENT: NON-SEVERABLE
Deborah Bunin · SRI International · funded by National Institutes of Health
2025–2027 · contract · N01
NICHD: R&D: PRECLINICAL SAFETY AND TOXICOLOGY STUDIES FOR REGULATORY REQUIREMENTS: NON-SEVERABLE
Deborah Bunin · SRI International · funded by National Institutes of Health
2025–2026 · contract · N01
TO CONDUCT SCREENING EFFORTS (TASK ORDER 5) FOR THE CHEMICAL SCREENING AND OPTIMIZATION FACILITY AND IDENTIFY NEW CHEMICAL MATTER FOR CONTRACEPTION AND REPRODUCTIVE HEALTH RELATED INDICATION
Leyi Gong · SRI International · funded by National Institutes of Health
2025–2027 · research · R21
Glymphatic MR Imaging and Biomarker Discovery in Aging with HIV Infection
Eva M Muller-Oehring · SRI International · funded by National Institutes of Health
2025–2027 · contract · N01
BIOLOGICAL TESTING FACILITY-REGULATORY, DATA ANALYSIS, DATABASE, AND PROJECT MANAGEMENT
Debra Burnin · SRI International · funded by National Institutes of Health
2025–2027 · contract · N01
NONCLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS FOR MEN AND/OR WOMEN
Debra Burnin · SRI International · funded by National Institutes of Health
2024–2025 · grant · Standard Grant
Conference: Quantum Learning through Experiential Activities and Practice (Q-LEAP) Workshop
Erin Weeks · SRI International · funded by National Science Foundation
2024–2025 · contract · N01
Task D16: Nonclinical Services for the Development of Interventional Agents for Antibiotic Resistant Infectious Diseases
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024–2026 · contract · N01
BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS
Debra Burnin · SRI International · funded by National Institutes of Health
2024–2026 · contract · N01
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support
Polly Yee Chang · SRI International · funded by National Institutes of Health
2024–2026 · contract · N01
BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES
Deborah Bunin · SRI International · funded by National Institutes of Health
2024–2026 · contract · N01
BIOLOGICAL TESTING FACILITY (BTF) – GOOD LABORATORY PRACTICE (GLP) TOXICOLOGY AND FERTILITY AND EARLY EMBRYONIC DEVELOPMENT (FEED) STUDIES AND PRECLINICAL STUDIES OF CONTRACEPTIVES
Debra Burnin · SRI International · funded by National Institutes of Health
2024–2029 · grant · Continuing Grant
Collaborative Research: An Observational Network to Enable Investigations of Gravity-Wave and Storm-Time Impacts on the Mid-Latitude Thermosphere-Ionosphere
Asti Bhatt · SRI International · funded by National Science Foundation
2024–2025 · contract · N01
Task D16: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024–2028 · grant · Continuing Grant
Collaborative Research: Supporting Teacher Customizations of an Integrated Science, Engineering, and Computational Thinking Curriculum Unit
Satabdi Basu · SRI International · funded by National Science Foundation
2024–2025 · contract · N01
Task D18: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
Jon Mirsalis · SRI International · funded by National Institutes of Health
2024–2026 · research · R21
Pilot in vivo trial with T-cell-based delivery of immunostimulatory proteins
Harikrishnan Radhakrishnan · SRI International · funded by National Institutes of Health
2024–2025 · grant · Continuing Grant
Topical Conferences for the NSF Eddie Bernice Johnson INCLUDES National Network
Leigh Delyser · SRI International · funded by National Science Foundation
2024–2025 · research · R61
Bioreactor for Manufacturing Chemotactically Competent Immune Cell Therapies
Xiaohe Liu · SRI International · funded by National Institutes of Health
2024 · contract · N01
Task A07: Updating Generic Version of Product Development Plan for Monoclonal Antibiotic-Resistant Antibodies
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024–2029 · research · R01
Nociceptin, NOPR and Sleep/Wake Control
Thomas S Kilduff · SRI International · funded by National Institutes of Health
2024–2025 · contract · N01
Task D16: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024–2027 · contract · N01
CHEMICAL SCREENING AND OPTIMIZATION FACILITY – HIGH THROUGHPUT SCREENING for Contraceptive Targets
Leyi Gong · SRI International · funded by National Institutes of Health
2024–2025 · contract · N01
DEVELOPMENT OF A NOVEL PLASMA PROTEIN BIOMARKER PANEL FOR A RADIATION/NUCLEAR TRIAGE BIODOSIMETRY DEVICE (RAPID RAD DX)
Hua Lin · SRI International · funded by National Institutes of Health
2024–2025 · contract · N01
Task D17: Non-Clinical Services for Development of Interventional Agents for Infectious Diseases
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024 · contract · N01
Task A07: Updating Generic Version of Product Development Plan for Monoclonal Antibodies
Jon Mirasilas · SRI International · funded by National Institutes of Health
2024–2026 · research · R21
Pilot in vivo trial with T-cell-based delivery of immunostimulatory proteins
Xiaohe Liu · SRI International · funded by National Institutes of Health
2024–2026 · contract · N01
DEVELOPMENT OF A NOVEL PLASMA PROTEIN BIOMARKER PANEL FOR A RADIATION/NUCLEAR TRIAGE BIODOSIMETRY DEVICE (RAPID RAD DX)
Hua Lin · SRI International · funded by National Institutes of Health
2024–2029 · research · R01
Nociceptin, NOPR and Sleep/Wake Control
Thomas S Kilduff · SRI International · funded by National Institutes of Health
2023–2025 · grant · U.S. Program
SRI International - to pilot Touchstones Instructional Coaching Tool
SRI International · funded by Bill and Melinda Gates Foundation